{
    "code": "20000021",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=20000021",
    "time": "2019-07-26 03:22:41",
    "許可證字號": "衛署罕藥輸字第000021號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "111\/07\/10",
    "發證日期": "101\/07\/10",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA02000002103",
    "中文品名": "愛服妥錠 2.5 毫克",
    "英文品名": "Votubia 2.5 mg tablets",
    "適應症": "「結節性硬化症併有腎血管肌脂肪瘤之成年病患」且須符合以下條件：其腎血管肌脂肪瘤最長直徑需≧4cm，且曾有發生臨床上有意義之出血或確認病灶有血管瘤（aneurysm）直徑≧5mm者，無法以外科手術或動脈栓塞治療，或經動脈栓塞治療或外科手術後無效或復發者。\r\n\r\n治療患有結節性硬化症(TS: tuberous sclerosis)相關腦室管膜下巨細胞星狀細胞瘤(SEGA: subependymal giant cell astrocytoma)且須介入治療但不適合接受治療性外科切除手術的患者。",
    "劑型": "110錠劑",
    "包裝": "4-1000粒鋁箔盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "06須由醫師處方使用",
    "主成分略述": "EVEROLIMUS",
    "主製造廠": {
        "申請商名稱": "0924601100  台灣諾華股份有限公司",
        "申請商地址": "台北市中正區仁愛路二段99號11、12、13樓",
        "主製造廠": "",
        "製造廠名稱": "FCH0099000  NOVARTIS PHARMA STEIN AG"
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "次製造廠": [
        {
            "製造廠名稱": "FCH0088200  NOVARTIS PHARMA AG",
            "製造廠廠址": "LICHTSTRASSE 35, CH-4056 BASEL, SWITZERLAND",
            "製造廠公司地址": "",
            "製造廠國別": "SWITZERLAND",
            "製程": "許可證持有者"
        }
    ],
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "9200099400",
            "成分名稱": "EVEROLIMUS",
            "含量描述": "(RAD n BHT)",
            "含量": "2.5000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "愛服妥錠-TWI-040119-回二校-108-01-18.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=20000021&Seq=013&Type=9"
        },
        {
            "title": "愛服妥錠2.5mg_FB-105-08-04.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=20000021&Seq=005&Type=8"
        }
    ]
}